Nymox Pharmaceutical Corp (NYMXF)

[MinnieM]

I'll agree that he isn't always correct, but, I have a question related to a comment you made on another board. I'm making it here since it would be off topic on the other one.

If their ph III trials were successful, why does it state the primary endpoints weren't met on their website.

http://www.nymox.com/default.action?itemid=23

The Company's Phase 3 U.S, pivotal studies failed to reach their Primary Endpoints.

They also have a webcast touting the drug, but, my suspicion is that there was no statistical difference between the drug and placebo or they wouldn't also state it hasn't met the endpoints in the ph III trials. http://limelightdc.com/clientarea/nymox_investor_webcast_7_15/player_vod.html

Have they given a reason for the reloation to the Bahamas?
http://www.nymox.com/resources/content/d248.pdf

On the positive side I see there was a motion to dismiss the suit brought against them: https://ecf.njd.uscourts.gov/doc1/119110619172

ORDER granting 32 Motion to Dismiss, and the Amended Complaint is dismissed w/prejudice. If Lead Plaintiffs wish to file a Second Amended complaint, they shall file a motion for leave to amend in accordance with the Local Rules no later that 2/24/16. Signed by Judge Jose L. Linares on 2/10/16. (sr, ) (Entered: 02/10/2016)

I haven't been following here and only ask due to your comments elsewhere.

I'd love to catch it on a low if in fact he's wrong on this one.









In Reply to '2014turnaround'
LOL he's usually correct you say? I could name 20 companies he was wrong about in the last 5 years alone!